Anti-diabetic effects of GLP-1 receptor agonists on obese and overweight patients across diabetes status, administration routes, treatment duration and baseline characteristics: A systematic review. - Wong HJ; Lin NHY; Teo YH; Yeo BSY; Toh KZX; Teo YN; Chan MY; Yeo LLL; Poh KK; Kong WKF; Eng PC; Tan BYQ; et al. (Diabetes, obesity & metabolism, 2025)